scholarly journals Recent Trends in Multipotent Human Mesenchymal Stem/Stromal Cells: Learning from History and Advancing Clinical Applications

2021 ◽  
Vol 25 (6) ◽  
pp. 342-357
Author(s):  
Kevin Dzobo
Cytotherapy ◽  
2018 ◽  
Vol 20 (9) ◽  
pp. 1110-1123 ◽  
Author(s):  
MARÍA DOLORES LÓPEZ-LUCAS ◽  
GISELA PACHÓN-PEÑA ◽  
ANA MARÍA GARCÍA-HERNÁNDEZ ◽  
ANTONIO PARRADO ◽  
DARÍO SÁNCHEZ-SALINAS ◽  
...  

Cells ◽  
2012 ◽  
Vol 1 (4) ◽  
pp. 1061-1088 ◽  
Author(s):  
Andrea Lindenmair ◽  
Tim Hatlapatka ◽  
Gregor Kollwig ◽  
Simone Hennerbichler ◽  
Christian Gabriel ◽  
...  

1993 ◽  
Vol 16 (5_suppl) ◽  
pp. 76-79 ◽  
Author(s):  
C. Carlo-Stella ◽  
L. Mangoni ◽  
V. Rizzoli

A number of clonogenic assays for short-term bone marrow culture is now available for the quantitative analysis of the various hematopoietic progenitor cell classes. The short-term assays are not suitable to analyse either stem cell selfrenewal or interactions of hematopoietic progenitors with stromal cells, especially those requiring direct cell-to-cell or cell-to-matrix contact. The technique of longterm bone marrow culture (LTBMC) allows a sustained production of myeloid cells when marrow is placed in liquid culture at relatively high cell concentration, with appropriate supplements, temperature and feeding conditions. A peculiar feature of LTBMC is that the stromal cells promote selfrenewal as well as differentiation of the stem cells, without the need to add exogenous growth factors. The LTBMC system offers an approach able to investigate not only the proliferative and differentiative events but also sustained cell production and selfrenewal of any clonogenic cell types. In the last years, the technique of LTBMC has been increasingly used by several groups to investigate hematopoietic regulation, stromal cell function and the interactions among stromal and hematopoietic cells. In the present report, the biology of LTBMC and their possible clinical applications will be reviewed.


Blood ◽  
2003 ◽  
Vol 102 (12) ◽  
pp. 4044-4051 ◽  
Author(s):  
Tetsuro-Takahiro Fujimoto ◽  
Satoshi Kohata ◽  
Hidenori Suzuki ◽  
Hiroshi Miyazaki ◽  
Kingo Fujimura

Abstract Megakaryocytes and functional platelets were generated in vitro from murine embryonic stem (ES) cells with the use of a coculture system with stromal cells. Two morphologically distinctive megakaryocytes were observed sequentially. Small megakaryocytes rapidly produced proplatelets on day 8 of the differentiation, and large hyperploid megakaryocytes developed after day 12, suggesting primitive and definitive megakaryopoiesis. Two waves of platelet production were consistently observed in the culture medium. A larger number of platelets was produced in the second wave; 104 ES cells produced up to 108 platelets. By transmission electron microscopy, platelets from the first wave were relatively rounder with a limited number of granules, but platelets from the second wave were discoid shaped with well-developed granules that were indistinguishable from peripheral blood platelets. ES-derived platelets were functional since they bound fibrinogen, formed aggregates, expressed P-selectin upon stimulation, and fully spread on immobilized fibrinogen. These results show the potential utility of ES-derived platelets for clinical applications. Furthermore, production of gene-transferred platelets was achieved by differentiating ES cells that were transfected with genes of interest. Overexpression of the cytoplasmic domain of integrin β3 in the ES-derived platelets prevented the activation of αIIbβ3, demonstrating that this system will facilitate functional platelet studies. (Blood. 2003;102:4044-4051)


Sign in / Sign up

Export Citation Format

Share Document